Newsroom

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, with a fireside chat at 10:00 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne BeOne Med...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 25.05.2026 FDNU IE00BG0SSC32 1,225,002.00 USD 46,302,938.81 37.798  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 25.05.2026 NQCYBREN IE00BF16M727 27,308,218.00 USD 1,422,042,271.26 52.074  ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--He-Man has faced countless villains, and now he’s teaming up with Krispy Kreme® to usher in a new era of doughnut deliciousness, defending flavor, fun and epic sweet cravings everywhere. Beginning Tuesday, May 26, at participating shops across the U.S., Krispy Kreme® in collaboration with Mattel and Amazon MGM Studios is unleashing the Masters of the Universe® Collection – three all-new doughnuts available for a limited time and a custom dozen box inspired by M...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--GlobalPlatform Launches Pavona: Open-source trusted silicon ecosystem with Post-Quantum Cryptography. 12 founding members join - with more to follow...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that six clinical abstracts demonstrating the broad use of its NeXT Personal® test will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 to June 2 in Chicago. Highlights include an oral podium presentation from the landmark TRACERx study, which demonstrates the clinical impact of NeXT Personal’s single-d...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced a major enhancement to its Panorama non-invasive prenatal test (NIPT). Powered by the company’s novel SNP-informed deep sequencing technology, Panorama NIPT is now backed by clinically-validated performance data in samples with low fetal fraction, enabling a no-call rate of 0.5%. Fetal fraction refers to the proportion of placental DNA circulating...

SAN FRANCISCO & ROTENBURG, Germany--(BUSINESS WIRE)--Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, and ARGUS Interception GmbH, a pioneer in net-based counter-UAS interception systems, announced today a strategic agreement under which ARGUS Interception will equip its A1-Falke® net-based interceptors with Ouster digital lidar. This collaboration combines the high-precision, short-range 3D detection capabilities of Ouster digital lid...

ORLANDO, Fla.--(BUSINESS WIRE)--Partnership Enables Residents Access to Streaming, FAST Channels, and Next-Generation Connected TV Services Through Local Fiber Broadband Provider...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 25.05.2026 FBTU.LN IE00BL0L0H60 475,002.00 USD 12,395,547.42 26.096  ...